This intricate interplay between neurons and glioma cells, mediated by paracrine signals such as BDNF, NLGN3, and IGF‐1, underscores the complexity of the TME in brain tumors and highlights potential therapeutic targets for future interventions. Here, IGF1 is linked to central nervous system cancer.